BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9862676)

  • 1. Epitope-specific antibody and suppression of autoantibody responses against a hybrid self protein.
    Lohnas GL; Roberts SF; Pilon A; Tramontano A
    J Immunol; 1998 Dec; 161(12):6518-25. PubMed ID: 9862676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking of B cell tolerance toward a highly conserved self protein.
    Dalum I; Jensen MR; Hindersson P; Elsner HI; Mouritsen S
    J Immunol; 1996 Dec; 157(11):4796-804. PubMed ID: 8943381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.
    Mikszta JA; Kim BS
    J Immunol; 1996 Oct; 157(7):2883-90. PubMed ID: 8816393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of T helper cell epitopes by using peptides spanning the 19-kDa protein of Mycobacterium tuberculosis. Evidence for unique and shared epitopes in the stimulation of antibody and delayed-type hypersensitivity responses.
    Ashbridge KR; Bäckström BT; Liu HX; Vikerfors T; Englebretsen DR; Harding DR; Watson JD
    J Immunol; 1992 Apr; 148(7):2248-55. PubMed ID: 1372026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity.
    Karopoulos C; Rowley MJ; Handley CJ; Strugnell RA
    J Autoimmun; 1995 Apr; 8(2):235-48. PubMed ID: 7542003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.
    Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J
    Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
    Gavioli R; Cellini S; Castaldello A; Voltan R; Gallerani E; Gagliardoni F; Fortini C; Cofano EB; Triulzi C; Cafaro A; Srivastava I; Barnett S; Caputo A; Ensoli B
    Vaccine; 2008 Jan; 26(5):727-37. PubMed ID: 18096278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.
    Lou YH; McElveen MF; Garza KM; Tung KS
    J Immunol; 1996 May; 156(9):3535-40. PubMed ID: 8617983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells.
    Harris DP; Vordermeier HM; Friscia G; Román E; Surcel HM; Pasvol G; Moreno C; Ivanyi J
    J Immunol; 1993 Jun; 150(11):5041-50. PubMed ID: 8496604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis.
    Brandt L; Oettinger T; Holm A; Andersen AB; Andersen P
    J Immunol; 1996 Oct; 157(8):3527-33. PubMed ID: 8871652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
    Cruz LJ; Quintana D; Iglesias E; Garcia Y; Huerta V; Garay HE; Duarte C; Reyes O
    J Pept Sci; 2000 May; 6(5):217-24. PubMed ID: 10823490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.
    Cruz LJ; Iglesias E; Aguilar JC; Cabrales A; Reyes O; Andreu D
    Bioconjug Chem; 2004; 15(5):1110-7. PubMed ID: 15366967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2-associated effects of flanking residues on the recognition of a permissive mycobacterial T-cell epitope.
    Román E; Harris DP; Jurcevic S; Ivanyi J; Moreno C
    Immunology; 1995 Oct; 86(2):183-9. PubMed ID: 7490116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient recognition by rat T cell clones of an epitope of mycobacterial hsp 65 inserted in Escherichia coli outer membrane protein PhoE.
    Hogervorst EJ; Agterberg M; Wagenaar JP; Adriaanse H; Boog CJ; Van De Zee R; Van Embden JD; Van Eden W; Tommassen J
    Eur J Immunol; 1990 Dec; 20(12):2763-8. PubMed ID: 1702727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.